Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Tristel ( (GB:TSTL) ) has shared an update.
Tristel plc announced the publication of a poster by the Mayo Clinic at the AORN Global Surgical Conference & Expo, detailing the successful trial of Tristel ULT™, a high-level disinfection foam for ultrasound probes. The trial, which involved 11 Mayo Clinic staff members and 189 ultrasound probes, reported no surgical site infections and highlighted the foam’s effectiveness, efficiency, and cost-effectiveness. This development follows recognition by the AAMI and ANSI of chlorine dioxide foam as a novel disinfection method and adds to the growing number of US case studies supporting Tristel ULT™. Tristel’s sales in North America are experiencing strong growth, with over 200,000 disinfection procedures conducted this financial year, reflecting increasing adoption and customer engagement.
Spark’s Take on GB:TSTL Stock
According to Spark, TipRanks’ AI Analyst, GB:TSTL is a Neutral.
Tristel’s overall score reflects its strong financial health and positive corporate events, tempered by bearish technical indicators. The balanced valuation provides an additional support to the stock’s prospects. Strategic growth initiatives and insider confidence bolster the company’s future outlook.
To see Spark’s full report on GB:TSTL stock, click here.
More about Tristel
Tristel plc is a global infection prevention company specializing in the manufacture and supply of products utilizing its unique proprietary chlorine dioxide chemistry. The company is a market leader in the manual decontamination of medical devices and provides sporicidal surface disinfection products under the Cache brand. Tristel operates globally with a head office in Snailwell, near Cambridge, employing around 270 people across 16 subsidiaries, and sells into over 40 countries. It targets annual revenue growth of 10% to 15% and maintains a profitable business with no debt.
YTD Price Performance: -35.41%
Average Trading Volume: 100,416
Technical Sentiment Signal: Strong Buy
Current Market Cap: £128.8M
See more insights into TSTL stock on TipRanks’ Stock Analysis page.